首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1532456

ELISA 分析儀市場 - 按類型、模式、模式、應用、最終用途 - 全球預測

ELISA Analyzers Market - By Type, Mode, Modality, Application, End-use - Global Forecast

出版日期: 2024年05月21日 | 出版商:

Global Market Insights Inc. | 英文 198 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

受基於患者獨特基因組成、生活方式和特定健康狀況的個人化醫療需求不斷成長的推動，全球 ELISA 分析儀市場從 2024 年到 2032 年的複合年成長率將超過 4.2%。隨著以患者為中心的醫療方法的發展，對提供精確和個人化結果的診斷工具的需求日益成長。舉個例子，2024 年 5 月，Thermo Fisher Scientific 推出了一系列新型先進 ELISA 分析儀，旨在提高個人化診斷的精確度和通量。這些工具旨在改善對客製化治療策略至關重要的生物標記的檢測。

此外，診斷技術的進步提高了 ELISA 分析儀的準確性和效率，有利於更廣泛的採用。糖尿病和癌症等慢性疾病的盛行率不斷上升，需要定期監測和診斷，而政府對醫療基礎設施的資助增加，支持在醫療設施中採用先進的診斷工具，將進一步提振市場前景。

ELISA 分析儀市場根據類型、模式、模式、應用、最終用途和區域進行細分。

在增強檢測能力和提高精度的需求的推動下，到 2032 年，光柵分析儀領域將實現顯著的複合年成長率。光柵技術提供卓越的靈敏度和解析度，能夠精確測量生物樣品。隨著研究和診斷應用變得越來越複雜，人們越來越重視獲得高度準確和可靠的結果。將先進的分析技術納入需要詳細和細緻資料的應用將刺激對光柵分析儀的需求。

由於營運效率和成本效益的平衡，到 2032 年，半自動 ELISA 分析儀將獲得大量市場佔有率。半自動化系統透過自動化重複性任務來簡化工作流程，同時允許手動監督，從而提高生產力，而無需承擔與全自動系統相關的高成本。這種組合對尋求提高通量和準確性同時管理預算限制的實驗室很有吸引力。隨著實驗室和研究機構繼續專注於最佳化流程和減少人為錯誤，半自動 ELISA 分析儀的採用預計將大幅增加。

由於對先進醫療保健和研究的高度重視，北美 ELISA 分析儀市場在預測期內將呈現值得注意的複合年成長率。對生物醫學 RampD 的大量投資，加上強大的醫療保健基礎設施，推動了對複雜診斷工具的需求。此外，慢性病盛行率的上升以及對個人化醫療的日益關注增加了對精確診斷解決方案的需求。高標準的醫療保健和支持性的監管環境有助於 ELISA 分析儀在北美地區的日益普及。

產業生態系統分析
產業影響力
- 成長動力
  - 慢性病和傳染病的盛行率不斷上升
  - 診斷測試的技術進步
  - 對攜帶式和自動化 ELISA 檢測的需求不斷成長
- 產業陷阱與挑戰
  - 嚴格的監管場景
  - 設備成本高
成長潛力分析
技術景觀
監管環境
定價分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
濾光片 ELISA 分析儀
光柵 ELISA 分析儀

第 6 章：市場估計與預測：按模式，2021 - 2032

主要趨勢
自動化 ELISA 分析儀
半自動 ELISA 分析儀

第 7 章：市場估計與預測：按模式，2021 - 2032 年

主要趨勢
桌上型
獨立式

第 8 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
免疫學
疫苗開發
藥品監測及製藥業
其他應用

第 9 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
生技公司
製藥公司
合約研究組織 (CRO)
診斷實驗室
其他最終用戶

第 10 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 11 章：公司簡介

Abbott Laboratories
Agilent Technologies, Inc.
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Danaher Corporation
DiaSorin S.p.A.
DYNEX Technologies
Erba Mannheim
F. Hoffmann-La Roche Ltd
Merck KGaA
PerkinElmer, Inc.
Randox Laboratories Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Tecan Group Ltd.
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 9569

Global ELISA Analyzers Market will witness over 4.2% CAGR from 2024 to 2032, driven by rising demand for personalized medicine based on a patient's unique genetic makeup, lifestyle, and specific health conditions. With an inclination towards patient-centric medical approaches, there is a growing need for diagnostic tools that offer precise and individualized results. Quoting an instance, in May 2024, Thermo Fisher Scientific launched a new range of advanced ELISA analyzers designed to enhance precision and throughput in personalized diagnostics. These tools aim to improve the detection of biomarkers critical for tailored treatment strategies.

Moreover, advancements in diagnostic technologies, which enhance the accuracy and efficiency of ELISA analyzers is favoring wider adoption. Rising prevalence of chronic diseases such as diabetes and cancer that necessitate regular monitoring and diagnostics, and increased government funding for healthcare infrastructure, which supports the adoption of advanced diagnostic tools in medical facilities will further bolster the market outlook.

The ELISA analyzers market is segmented based on type, mode, modality, application, end-use, and region.

The optical grating analyzers segment will record a remarkable CAGR through 2032, driven by the need for enhanced detection capabilities and improved accuracy. Optical grating technology offers superior sensitivity and resolution, enabling precise measurements of biological samples. As research and diagnostic applications become increasingly complex, there is a growing emphasis on obtaining highly accurate and reliable results. The incorporation of advanced analytical techniques for applications requiring detailed and nuanced data will fuel the demand for optical grating analyzers.

The semi-automated ELISA analyzers will procure a substantial market share by 2032, owing to the balance of operational efficiency and cost-effectiveness. Semi-automated systems streamline workflows by automating repetitive tasks while allowing for manual oversight, which enhances productivity without the high costs associated with fully automated systems. This combination appeals to laboratories seeking to improve throughput and accuracy while managing budget constraints. As laboratories and research facilities continue to focus on optimizing their processes and reducing manual errors, the adoption of semi-automated ELISA analyzers is expected to rise significantly.

North America ELISA analyzers market will exhibit a noteworthy CAGR during the forecast period, because of the strong emphasis on advanced healthcare and research. Significant investments in biomedical R&D, coupled with robust healthcare infrastructure, propel the need for sophisticated diagnostic tools. Additionally, the rising prevalence of chronic diseases and the increasing focus on personalized medicine boost the demand for precise diagnostic solutions. The high standard of medical care and supportive regulatory environment contribute to the growing adoption of ELISA analyzers across North America.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing prevalence of chronic and infectious diseases
  - 3.2.1.2 Technological advancements in diagnostic testing
  - 3.2.1.3 Rising demand for portable and automated ELISA assays
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory scenario
  - 3.2.2.2 High cost of devices
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Optical filter ELISA analyzers
5.3 Optical grating ELISA analyzers

Chapter 6 Market Estimates and Forecast, By Mode, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Automated ELISA analyzers
6.3 Semi-automated ELISA analyzers

Chapter 7 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Bench-top
7.3 Stand-alone

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Immunology
8.3 Vaccine development
8.4 Drug monitoring & pharmaceutical industry
8.5 Other applications

Chapter 9 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Biotechnology companies
9.3 Pharmaceutical companies
9.4 Contract research organizations (CROs)
9.5 Diagnostic laboratories
9.6 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.5.4 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa